SCHEMBL6153715

SCHEMBL6153715

N#Cc1cccc(Oc2cccc(C=O)c2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 1/20 0.46
MAOA P21397 6/20 0.44
MAOB P27338 6/20 0.44
P4HB P07237 1/20 0.44
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
FBP1 P09467 3/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
PGR P06401 1/20 0.42
EPAS1 Q99814 2/20 0.41
ATM Q13315 1/20 0.41
VEGFA P15692 1/20 0.40
GRIA2 P42262 1/20 0.40
NPC1 O15118 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3163442 0.89 PGR (0.47) P4HBPDE4APDE4BPDE4CPDE4D
SCHEMBL4104432 0.89 CYP19A1 (0.47) SRCMAOAMAOBPDE4APDE4B
SCHEMBL29463498 0.84 FBP1 (0.56) MAOAMAOBP4HBFBP1ALDH1A1
SCHEMBL67236 0.84 FBP1 (0.56) MAOAMAOBP4HBFBP1ALDH1A1
SCHEMBL8379001 0.84 PDE4A (0.54) PDE4APDE4BPDE4CPDE4DPGR
SCHEMBL6849018 0.84 SRC (0.60) SRCMAOAMAOBMEN1ALDH1A1
SCHEMBL30631693 0.84 SRC (0.60) SRCMAOAMAOBMEN1ALDH1A1
SCHEMBL14662294 0.82 SLC22A12 (0.47) MEN1ALDH1A1LMNAMAPTKMT2A
SCHEMBL6557043 0.82 MAOA (0.51) SRCMAOAMAOBMEN1ALDH1A1
SCHEMBL6852137 0.82 SRC (0.58) SRCMAOAMAOBMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases METABASIS THERAPEUTICS, INC. 2005-03-24 US disclosed
EP-1446110-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES Structural Bioinformatics Inc. (US) 2004-08-18 EP disclosed
WO-2003032916-A2 ORGANOSULFUR INHIBITORS OF TYROSINE PHOSPHATASES STRUCTURAL BIOINFORMATICS INC. (US) 2003-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065118-A1 Organosulfur inhibitors of tyrosine phosphatases PTPRS, PTPRJ, PTPRCAP SRC 71/4885MAOA 4410/4885MAOB 3660/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.